46.88
+4.76%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥6.57bn
FY2016FY2025
Net income
CN¥591.3m
FY2016FY2025
Free cash flow
CN¥515.9m
FY2016FY2025
Shareholders' equity
CN¥4.78bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥6.57bn | CN¥4.95bn | CN¥4.84bn | CN¥4.81bn | CN¥3.83bn | CN¥2.60bn | CN¥2.11bn | CN¥2.52bn | CN¥1.99bn | CN¥1.55bn |
| Research and development | CN¥552.3m | CN¥514.0m | CN¥497.2m | CN¥493.6m | CN¥461.8m | CN¥371.2m | CN¥283.4m | CN¥287.8m | CN¥253.3m | CN¥197.2m |
| Operating income | CN¥626.6m | CN¥472.9m | CN¥410.2m | CN¥381.4m | CN¥196.2m | CN¥288.9m | CN¥366.7m | CN¥339.0m | CN¥80.7m | CN¥298.3m |
| Net income | CN¥591.3m | CN¥398.4m | CN¥390.4m | CN¥331.4m | CN¥193.3m | CN¥239.2m | CN¥286.5m | CN¥323.0m | CN¥80.4m | CN¥276.0m |
| Diluted earnings per share | 1.32 | 0.89 | 0.87 | 0.79 | 0.48 | 0.66 | 0.80 | 0.90 | 0.18 | 0.61 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥12.84bn | CN¥8.90bn | CN¥7.82bn | CN¥7.62bn | CN¥5.64bn | CN¥4.33bn | CN¥2.69bn | CN¥2.98bn | CN¥2.42bn | CN¥1.70bn |
| Cash and short-term investments | — | CN¥981.9m | CN¥1.32bn | CN¥1.43bn | CN¥525.8m | CN¥761.2m | CN¥576.7m | CN¥590.7m | CN¥122.7m | CN¥436.6m |
| Total liabilities | CN¥7.90bn | CN¥4.46bn | CN¥3.64bn | CN¥3.84bn | CN¥3.20bn | CN¥2.54bn | CN¥1.19bn | CN¥1.77bn | CN¥1.51bn | CN¥791.7m |
| Debt | CN¥1.09bn | CN¥1.20bn | CN¥1.66bn | CN¥1.52bn | CN¥1.28bn | CN¥1.02bn | CN¥464.8m | CN¥439.1m | CN¥556.7m | CN¥221.6m |
| Shareholders' equity | CN¥4.78bn | CN¥4.46bn | CN¥4.18bn | CN¥3.75bn | CN¥2.40bn | CN¥1.76bn | CN¥1.50bn | CN¥1.20bn | CN¥908.6m | CN¥919.4m |
| Shares outstanding | 449m | 446m | 446m | 419m | 399m | 361m | 360m | 360m | 449m | 449m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥671.6m | CN¥318.8m | −CN¥49.7m | −CN¥7.1m | −CN¥589.4m | −CN¥212.6m | CN¥200.9m | CN¥794.1m | −CN¥156.8m | CN¥120.7m |
| Capital spending | −CN¥155.7m | −CN¥194.2m | −CN¥100.7m | −CN¥131.3m | −CN¥269.0m | −CN¥222.9m | −CN¥106.5m | −CN¥164.6m | −CN¥221.2m | −CN¥103.5m |
| Free cash flow | CN¥515.9m | CN¥124.6m | −CN¥150.4m | −CN¥138.5m | −CN¥858.3m | −CN¥435.6m | CN¥94.3m | CN¥629.5m | −CN¥378.0m | CN¥17.3m |
| Dividends paid | −CN¥159.2m | −CN¥157.5m | −CN¥48.1m | −CN¥50.8m | −CN¥37.3m | −CN¥23.2m | −CN¥11.0m | −CN¥43.4m | −CN¥303.6m | −CN¥9.9m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥1.76bn | CN¥1.48bn | CN¥2.92bn | CN¥1.78bn | CN¥1.14bn | CN¥737.0m | CN¥1.68bn | CN¥1.44bn |
| Operating income | CN¥176.4m | CN¥53.6m | CN¥297.0m | CN¥176.6m | CN¥187.2m | −CN¥23.5m | CN¥155.9m | CN¥184.0m |
| Net income | CN¥228.8m | CN¥28.5m | CN¥259.0m | CN¥169.8m | CN¥193.6m | −CN¥31.0m | CN¥144.5m | CN¥158.0m |
| Diluted earnings per share | 0.51 | 0.06 | 0.58 | 0.38 | 0.43 | -0.07 | 0.32 | 0.35 |
| Cash from operations | — | — | — | CN¥412.0m | CN¥250.0m | CN¥48.0m | — | CN¥477.0m |
| Capital spending | −CN¥143.0m | −CN¥102.0m | −CN¥98.0m | −CN¥25.0m | −CN¥21.0m | −CN¥9.0m | −CN¥132.0m | −CN¥53.0m |
| Free cash flow | — | — | — | CN¥387.0m | CN¥229.0m | CN¥39.0m | — | CN¥424.0m |
| Total assets | CN¥15.97bn | CN¥14.17bn | CN¥12.84bn | CN¥12.10bn | CN¥10.84bn | CN¥9.31bn | CN¥8.90bn | CN¥8.90bn |
| Cash and short-term investments | — | — | — | CN¥1.74bn | CN¥1.38bn | CN¥1.40bn | CN¥981.9m | CN¥1.29bn |
| Debt | CN¥1.95bn | CN¥1.62bn | CN¥1.09bn | CN¥2.42bn | CN¥1.33bn | CN¥1.42bn | CN¥1.16bn | CN¥2.51bn |
| Shareholders' equity | CN¥5.08bn | CN¥4.80bn | CN¥4.78bn | CN¥4.74bn | CN¥4.56bn | CN¥4.42bn | CN¥4.46bn | CN¥4.31bn |
Financial ratios
Data as of 23 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 9.5% | 9.5% | 8.5% | 7.9% | 5.1% | 11.1% |
| Net margin | 9.0% | 8.0% | 8.1% | 6.9% | 5.1% | 9.2% |
| Return on equity | 12.4% | 8.9% | 9.3% | 8.8% | 8.1% | 13.6% |
| Return on assets | 4.6% | 4.5% | 5.0% | 4.3% | 3.4% | 5.5% |
| Free cash flow yield | 3.9% | 2.4% | 0.2% | 0.6% | -1.7% | 0.1% |
| Revenue growth | 32.6% | 2.4% | 0.6% | 25.7% | 47.4% | 23.0% |
| Earnings growth | 48.4% | 2.0% | 17.8% | 71.4% | -19.2% | -16.5% |
| Current ratio | 1.65x | 1.83x | 2.06x | 1.95x | 1.51x | 1.54x |
| Debt to equity | 0.23x | 0.26x | 0.39x | 0.40x | 0.53x | 0.58x |
| Equity ratio | 37.2% | 50.1% | 53.4% | 49.3% | 42.5% | 40.6% |
| Interest coverage | 11.74x | 6.88x | 7.36x | 7.01x | 5.51x | 11.72x |
| R&D as a share of sales | 8.4% | 10.4% | 10.3% | 10.3% | 12.1% | 14.3% |
| Buybacks as a share of market value | -0.7% | 0.1% | -6.5% | -4.9% | -10.7% | -0.3% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 10.9% | 20.4% | — |
| Operating income | 18.0% | 16.8% | — |
| Net income | 21.3% | 19.8% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | 28.7 | 29.4 | 38.4 | 36.2 | 96.4 |
| Price to sales | 2.6 | 2.4 | 3.1 | 2.5 | 4.9 |
Dividends and splits
Per share, in the currency the company pays
Paid for 2 years. Last went ex-dividend on 20 Jul 2026.
| FY2026 | FY2025 | FY2024 | |
|---|---|---|---|
| Paid in the year | 0.148 | 0.235 | 0.215 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.